- Human Papilloma virus (HPV) infection leads to cervical cancer and genital warts.
- Centers for Disease Control and Prevention recommends two shots of HPV vaccine for young adolescents.
- The U.S. Food and Drug Administration also approved the two dose HPV vaccine schedule for preteens.
The Centers for Disease Control and Prevention (CDC) has recently decreased the dose of HPV vaccine for the treatment of cervical cancer in preteens.
Human Papilloma Virus (HPV) infections generally lead to cervical cancer and genital warts. These infections commonly spread through sex. Immunizing the kids at the age of 11 or 12 prevents HPV infections.
CDC recently recommends that preteens can receive two doses of HPV vaccine atleast six months apart when compared to the previous three dose for infections. And teens and young adults between 15 -26 years of age can continue with three dose of vaccine for infections.
According to the Centers for Disease Control and Prevention, around 80 million Americans are affected by HPV infections.
Preteens usually receive HPV along with whooping cough and meningitis vaccine. Two doses of HPV vaccine at the age of 11 and 12 with six months gap may help in the prevention of infections.
The Advisory Committee on Immunization Practices (ACIP) is a panel of experts who advise CDC on vaccine recommendations in the United States. They have voted for a 2 dose schedule of vaccine for infections. CDC has approved the recommendations of ACIP for HPV vaccine schedule and the agency guidelines were published in the Morbidity and Mortality Weekly Report (MMWR).
The United States Food and Drug Administration has also approved 2 dose vaccine for preteens between 9 -14 years of age. CDC provides guidance and encourages parents and healthcare professionals to implement 2-dose schedule for protecting their children from HPV cancers.